PMDA drug package insert
アデカット7.5mg錠
PMDA Prescription drug · T's製薬株式会社 · package insert Dec 24, 2025
Key facts
| Brand names | アデカット7.5mg錠, アデカット15mg錠, アデカット30mg錠 |
|---|---|
| Nonproprietary names | デラプリル塩酸塩 |
| Companies | 製造販売元／T's製薬株式会社, 販売／武田薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ACE-I注）降圧剤 注）ACE-I：アンジオテンシンⅠ変換酵素阻害剤 |
| Therapeutic category codes | 872144 |
| YJ codes | 2144004F1023, 2144004F2020, 2144004F3026 |
| Approval numbers | 20100AMZ00023, 20100AMZ00024, 20100AMZ00025 |
| Package insert edition | 第5版 |
| Package insert date | Dec 24, 2025 |
| PMDA document key | 400061_2144004F1023_2 |
| PMDA company code | 400061 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: